@gallusbiopharma.com
Gallus Biopharmaceuticals, LLC, a contract manufacturer, supplies clinical and commercial bulk biologics to the biopharmaceutical industry
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Gallus Biopharma is a biopharmaceutical company based in the United States that specializes in the development and manufacturing of biopharmaceutical products. The company was founded in 2010 and is headquartered in St. Louis, Missouri.
Gallus Biopharma offers a wide range of products and services to its clients. The company provides process development, analytical characterization, and cGMP manufacturing services for biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and vaccines. Gallus Biopharma's capabilities span from early-stage development to commercial manufacturing, offering a comprehensive solution to its clients.
In terms of global operations, Gallus Biopharma has expanded its reach through various partnerships and collaborations. The company has formed strategic alliances with several pharmaceutical and biotechnology companies to enhance its capabilities and broaden its customer base. These collaborations have allowed Gallus Biopharma to tap into new markets and gain access to innovative technologies.
Gallus Biopharma's market position is significant, with a strong presence in the global biopharmaceutical industry. The company has established itself as a leading contract development and manufacturing organization (CDMO) and has achieved steady growth over the years. It competes with other major players in the CDMO market, such as Lonza, Catalent, and Patheon.
The company has had several major achievements and events that have contributed to its growth. In 2016, Gallus Biopharma was acquired by DPx Holdings B. V., a leading global CDMO.
This acquisition expanded Gallus Biopharma's capabilities and provided access to DPx Holdings' extensive global network. As of the latest information available, Gallus Biopharma continues to operate as an independent subsidiary of DPx Holdings. The company is focused on expanding its capabilities and serving a diverse array of clients in the biopharmaceutical industry.
Gallus Biopharma strives to deliver high-quality biopharmaceutical products and services while maintaining its position as a leader in the CDMO market
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories